Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × spartalizumab × Clear all

NCT02325739 2024-10-21

FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression

Phase 1/2 Completed

172 enrolled 33 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT04652440 2023-04-19

Ablation Combined With PD-1 in HCC: Phase II Study

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular